Institute for Cell and Molecular Biosciences, Newcastle University, Medical School, Catherine Cookson Building, Framlington Place, Newcastle Upon Tyne NE2 4HH, UK.
Nat Rev Cancer. 2012 Jan 19;12(2):121-32. doi: 10.1038/nrc3204.
It is only recently that the full importance of nuclear factor-κB (NF-κB) signalling to cancer development has been understood. Although much attention has focused on the upstream pathways leading to NF-κB activation, it is now becoming clear that the inhibitor of NF-κB kinases (IKKs), which regulate NF-κB activation, have many independent functions in tissue homeostasis and normal immune function that could compromise the clinical utility of IKK inhibitors. Therefore, if the NF-κB pathway is to be properly exploited as a target for both anticancer and anti-inflammatory drugs, it is appropriate to reconsider the complex roles of the individual NF-κB subunits.
直到最近,人们才充分认识到核因子-κB(NF-κB)信号对癌症发展的重要性。虽然人们已经关注了导致 NF-κB 激活的上游途径,但现在越来越清楚的是,调节 NF-κB 激活的 NF-κB 激酶抑制剂(IKK)在组织稳态和正常免疫功能方面具有许多独立的功能,这可能会影响 IKK 抑制剂的临床应用。因此,如果要将 NF-κB 途径适当地作为抗癌和抗炎药物的靶点,那么重新考虑 NF-κB 亚基的复杂作用是恰当的。